88
6
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1889 |
MCL0020
MCL 0020 |
Melanocortin Receptor | GPCR/G Protein; Neuroscience |
MCL0020 是一种有效的选择性黑素皮质素MC4受体拮抗剂,IC50为 11.63 nM。它剂量依赖性减轻束缚应激诱发的厌食症,在体内表现出抗焦虑样活性。 | |||
T12041 |
MIM1
Inhibitor of Mcl-1 |
BCL | Apoptosis |
MIM1 (Inhibitor of Mcl-1) 是一种骨髓细胞因子 1 抑制剂。 | |||
T40230 |
Mcl-1 inhibitor 6
|
||
Mcl-1 inhibitor 6 is a potent, orally active chemical compound that selectively inhibits the myeloid cell leukemia 1 (Mcl-1) protein, with a high affinity (K d = 0.23 nM) and binding activity (K i = 0.02 μM). This compound exhibits exceptional selectivity over other members of the Bcl-2 family, including Bcl-2, Bcl2A1, Bcl-xL, and Bcl-w (K d >10 μM). Notably, Mcl-1 inhibitor 6 demonstrates strong antitumor activity. | |||
T11967 |
Mcl-1 antagonist 1
|
Others | Others |
Mcl-1 antagonist 1 is a Mcl-1 protein antagonist. | |||
T11972 |
Mcl-1 inhibitor 3
|
BCL | Apoptosis |
Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity.Mcl-1 inhibitor 3 is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). | |||
T27986 |
MCL0129
MCL-0129,MCL 0129 |
||
MCL0129, a selective and non-peptidergic melanocortin 4 (MC4) receptor antagonist, is a potential treatment for cachexia. | |||
T11971 |
MCL-1/BCL-2-IN-4
|
Others | Others |
MCL-1/BCL-2-IN-4 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor. | |||
T11969 |
MCL-1/BCL-2-IN-2
|
Others | Others |
MCL-1/BCL-2-IN-2 is a potent and selective Bcl-2 and Mcl-1 dual inhibitor. | |||
T11970 |
MCL-1/BCL-2-IN-3
|
Others | Others |
MCL-1/BCL-2-IN-3 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor with IC50s of 5.95 and 4.78 μM, respectiely. | |||
T11968 |
MCL-1/BCL-2-IN-1
|
BCL | Apoptosis |
MCL-1/BCL-2-IN-2 (Compound Nap-1) 是一种有效的选择性 Mcl-1和 Bcl-2双重抑制剂,IC50分别为 4.45 和 3.18 μM。 | |||
T27996 |
MDK-3298
Mcl-1 Inhibitor-5,Mcl-1 Inhibitor 5,MDK3298,Mcl-1 Inhibitor5 |
||
MDK-3298 is a reversible covalent inhibitor of Mcl-1, a target of protein-protein interaction (PPI). | |||
T27997 |
MDK-3345
MDK 3345,Mcl-1 Inhibitor11,Mcl-1 Inhibitor 11,Mcl-1 Inhibitor-11 |
||
MDK-3345 is a reversible covalent inhibitor for Mcl-1. | |||
T79242 |
Mcl-1 inhibitor 16
|
||
Mcl-1 inhibitor16 (Compound 9)为基于铂的线粒体靶向性Mcl-1抑制剂。该化合物通过诱导Bax/Bak依赖的细胞凋亡(apoptosis),展现出对癌细胞的作用,可以单独使用或与ABT-199联合应用,表现出抗肿瘤活性。 | |||
T79036 | Mcl-1 inhibitor 13 | ||
Mcl-1 inhibitor13 (Example 9),一种MCL-1抑制剂(Ki: 8.2 nM),主要用于癌症相关研究。 | |||
T79215 |
Mcl-1 inhibitor 14
|
||
Mcl-1 inhibitor14 (Compound (Ra)-10)作为一种优异的髓系细胞白血病-1 (MCL-1) 抑制剂,其Ki值为0.018 nM,主要应用于抗癌研究领域。 | |||
T79216 |
Mcl-1 inhibitor 15
|
||
Mcl-1 inhibitor15 (Compound (Ra)-15),作为一种高效的Mcl-1抑制剂(Ki: 0.02 nM),主要应用于癌症的研究领域。 | |||
T75143 | Mcl-1 inhibitor 12 | ||
Mcl-1 inhibitor12 (Example 10) 作为一种高效的MCL-1抑制剂 (Ki: 0.22 nM),主要应用于癌症研究领域。 | |||
T72610 |
Mcl-1 inhibitor 9
|
||
Mcl-1 inhibitor9 (example 2) 是一种 myeloid cell leukemia 1(Mcl-1) 抑制剂,IC50值为 0.21889 nM,其具有抗肿瘤活性。 | |||
T62249 |
Bcl-2/Mcl-1-IN-1
|
||
Bcl-2/Mcl-1-IN-1 是一种 Bcl-2 (Ki: 4.53 μM) 和 Mcl-1 (Ki: 1.19 μM) 抑制剂。Bcl-2/Mcl-1-IN-1 能够用于研究癌症。 | |||
T62443 |
Bcl-2/Mcl-1-IN-2
|
||
Bcl-2/Mcl-1-IN-2 是一种 Bcl-2 (Ki: 4.70 μM) 和 Mcl-1 (Ki: 0.88 μM) 抑制剂。Bcl-2/Mcl-1-IN-2 能够用于研究癌症。 | |||
T62941 | Bcl-2/Mcl-1-IN-3 | ||
Bcl-2/Mcl-1-IN-3 是一种 Bcl-2/Mcl-1 抑制剂,作用于 Mcl-1 (Ki: 0.14 μM) 和 Bcl-2 (Ki: 0.23 μM),能够用于研究癌症。 | |||
T10096L |
Voruciclib
|
CDK | Cell Cycle/Checkpoint |
Voruciclib 是一种具有口服活性和选择性 CDK 抑制剂,Ki 为 0.626 nM-9.1 nM。它在多种弥漫性大 B 细胞淋巴瘤模型中抑制 MCL-1 的表达。它有效阻断 MCL-1 的转录调节子 CDK9。 | |||
T18487 |
NH2-C6-NH-Boc
|
Others; PROTAC Linker | Others; PROTAC |
NH2-C6-NH-Boc 是一种属于 alkyl/ether 类的 PROTAC linker ,是基于 PROTAC 技术的 Mcl-1 抑制剂。 | |||
T16156 |
MT 63-78
|
Apoptosis; AMPK; mTOR | Apoptosis; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
MT 63-78 是一种有效的直接AMPK 激活剂,EC50为 25 μM。它诱导细胞有丝分裂阻滞和细胞凋亡,通过抑制脂肪生成和mTORC1途径来阻止前列腺癌的生长,具有抗肿瘤作用。 | |||
T16027 |
Mcl1-IN-1
|
Others | Others |
Mcl1-IN-1 is a myeloid cell factor 1 inhibitor (IC50=2.4 µM). | |||
T68398 |
MI-223
|
||
MI-223 is an inhibitor of Mcl-1-stimulated homologous recombination (HR) DNA repair, which leads to sensitization of cancer cells to hydroxyurea- or olaparib-induced DNA replication stress. | |||
T11973 |
Mcl1-IN-11
|
BCL | Apoptosis |
Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively. | |||
T11977 | Mcl1-IN-9 | BCL | Apoptosis |
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. | |||
T11974 | Mcl1-IN-12 | BCL | Apoptosis |
Mcl1-IN-12 has anti-tumor activity.It is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.29 and 3.1 μM, respectively. | |||
T16029 |
Mcl1-IN-3
|
Others | Others |
Mcl1-IN-3 is an Mcl1 inhibitor. It has an IC50 and Ki of 0.67 and 0.13 μM, respectively. | |||
T16028 |
IMB-XH1
Mcl1-IN-2,7-[(2-吡啶基氨基)-2-噻吩基甲基]-8-喹啉醇 |
BCL; Antibacterial | Apoptosis; Microbiology/Virology |
IMB-XH1 (Mcl1-IN-2) 是一种骨髓细胞因子 1 抑制剂。它也是非竞争性的 Delhi metallo-β-lactamase(NDM-1) 抑制剂。它对金属 β-内酰胺酶 NDM-1,IMP-4,ImiS 和 L1 的 IC50值分别为 0.4637 μM,3.980 μM,0.2287 μM 和 1.158 μM。 | |||
T16030 | Mcl1-IN-8 | Others | Others |
Mcl1-IN-8 is an Mcl-1-PUMA interface inhibitor (Ki: 0.3 μM). In cancer cells, Mcl1-IN-8 shows dual activity on reducing PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis. | |||
T11976 | Mcl1-IN-4 | Others | Others |
Mcl1-IN-4 is an inhibitor of Mcl1 ( IC50:0.2 μM). | |||
T24436 |
Mcl1-IN-26
|
||
Mcl1-IN-26 is an effective and selective myeloid cell leukemia 1 inhibitor. | |||
T2558 |
Cladribine
2-chlorodeoxyadenosine,克拉屈滨,2-Chloro-2′-deoxyadenosine,CldAdo,2CdA |
Apoptosis; Adenosine deaminase | Apoptosis; Metabolism |
Cladribine (2CdA) 是一种嘌呤核苷类似物,是具有口服活性的腺苷脱氨酶抑制剂。它能作为 DNA 合成的抑制剂,可阻断受损 DNA 的修复。它可抑制 DNA 甲基化,具有抗淋巴瘤活性,可研究血液恶性肿瘤和多发性硬化。 | |||
T11975 |
PROTAC Mcl1 degrader-1
|
BCL; PROTACs | Apoptosis; PROTAC |
PROTAC Mcl1 degrader-1 induces the ubiquitination and proteasomal degradation of Mcl-1 by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1 inhibitor S1-6 with μM-range affinity. PROTAC Mcl1 degrader-1, a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM. | |||
T19024 |
MCLA hydrochloride
|
Others | Others |
MCLA hydrochloride, a chemiluminescent compound, can be used to quantify aqueous concentrations of superoxide. | |||
T13657 |
dMCL1-2
|
Others | Others |
dMCL1-2 is a potent and selective myeloid leukemia 1 (MCL1) degrading agent based on PROTAC, which binds to MCL1 with a KD of 30 nM. dmcl-2 activates the apoptosis mechanism by degrading MCL1. | |||
T24812 |
SOMCL-863
|
||
SOMCL-863 is a selective and orally bioavailable c-Met inhibitor. It shows antitumor activity both in vitro and in vivo. | |||
T2632 |
A-1210477
|
Apoptosis; BCL | Apoptosis |
A-1210477 是一种选择性的MCL-1有效抑制剂,Ki 值为 0.45 nM。它特异性结合 MCL-1,并以 MCL-1 依赖性方式促进癌细胞凋亡。 | |||
T6281 |
TW-37
TW 37 |
BCL | Apoptosis |
TW-37 是重组 Bcl-2、Bcl-xL 和 Mcl-1 的非肽抑制剂,Ki 值分别为 0.26、0.29和1.11μM | |||
T17247 |
VU0661013
VU661013 |
BCL | Apoptosis |
VU0661013 是一种有效的选择性 MCL-1 抑制剂。 | |||
T5108 |
ML311
|
BCL | Apoptosis |
ML311 是 Mcl-1/Bim 相互作用的一种选择性抑制剂。 | |||
T6034 |
UMI-77
UMI77,UMI 77 |
BCL | Apoptosis |
UMI-77是一种选择性的Mcl-1抑制剂,结合到Mcl-1的 BH3 结合沟,Ki 值为 490 nM,对 Bcl-2 家族的其他成员具有选择性。 | |||
T5346 |
S63845
|
BCL | Apoptosis |
S63845 是一种选择性骨髓细胞白血病 1 抑制剂,结合人 MCL1的 Kd 值为 0.19 nM。 | |||
T13639 |
Deferasirox (Fe3+ chelate)
|
Apoptosis | Apoptosis |
Deferasirox (Fe3+ chelate) 是一种可口服的铁螯合剂,具有潜在的抗癌活性,抑制 MCL-1 的抗凋亡活性,可用于研究铁超负荷。 | |||
T6650 |
Sabutoclax
BI-97C1 |
BCL | Apoptosis |
Sabutoclax (BI-97C1) 是一种泛 Bcl-2 抑制剂,包括 Bcl-xL、Bcl-2、Mcl-1 和 Bfl-1,IC50 分别为 0.31 μM、0.32 μM、0.20 μM 和 0.62 μM。 | |||
T11944 |
Maritoclax
Marinopyrrole A |
BCL | Apoptosis |
Maritoclax (Marinopyrrole A) 是一种新型特异性 Mcl-1 抑制剂,IC50值为 10.1 μM,对 BCL-xl 的 IC50值 > 80 μM。 | |||
T6396 |
(R)-(-)-Gossypol acetic acid
(-)-Gossypol acetic acid,AT-101 (acetic acid),(R)-Gossypol acetic acid,AT101醋酸,AT101,AT101 acetate |
BCL; Autophagy | Apoptosis; Autophagy |
(R)-(-)-Gossypol acetic acid (AT101 acetate) 是天然产物 Gossypol 的左旋异构体,与 Bcl-2、Bcl-xL 和 Mcl-1 结合,Ki 为 0.32 μM、0.48 μM 和 0.18 μM。 | |||
T14665L |
Motixafortide TFA(664334-36-5,Free)
TF 14016 TFA,BKT140 TFA,BL-8040 TFA,T140 TFA |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Motixafortide TFA(664334-36-5,Free) (BKT140 TFA) 是 CXCR4 的拮抗剂,IC50 为 ~1 nM。它通过改变 miR-15a/16-1 表达下调 ERK、BCL-2、MCL-1 和 cyclin-D1 来诱导 AML 原始细胞凋亡。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6185 |
Gambogic Acid
藤黄酸,Beta-Guttiferrin,藤黄酸 A,Guttatic Acid,Guttic Acid |
BCL; Autophagy | Apoptosis; Autophagy |
Gambogic Acid (Guttic Acid) 是来自藤黄树的一种藤黄树脂,抑制 Bcl-XL、Bcl-2、Bcl-W、Bcl-B、Bfl-1和 Mcl-1,IC50分别为 1.47 μM、1.21 μM、2.02 μM、0.66 μM、1.06 μM 和 0.79 μM。 | |||
T5688 |
Micheliolide
|
NOS; NF-κB; COX | Immunology/Inflammation; Neuroscience; NF-κB |
Micheliolide 是一种倍半萜内酯,能够抑制各种炎症反应。它能减弱高糖刺激的NF-κB 活化,IκBα的降解,和MCP-1,TGF-β1,FN 在鼠系膜细胞的表达。 | |||
T5668 |
Triacetylresveratrol
乙酰化白藜芦醇,三乙酰基白藜芦醇,Acetyl-trans-resveratrol |
BCL; NF-κB; STAT | Apoptosis; JAK/STAT signaling; NF-κB; Stem Cells |
Triacetylresveratrol (Acetyl-trans-resveratrol) 是 Resveratrol 的乙酰化类似物,可降低 STAT3和 NF-κB 磷酸化,具有抗癌作用。 | |||
T2730 |
Gossypol (acetic acid)
(±)-Gossypol-acetic acid,Pogosin,AT101,醋酸棉酚,乙酸棉子酚,Gossypol acetic acid |
BCL | Apoptosis |
Gossypol acetic acid (AT101) 是一种从棉籽中分离出来的多酚天然产物,分别与 Bcl-xL 蛋白和 Bcl-2蛋白结合,Ki 值分别为 0.5-0.6 μM 和 0.2-0.3 mM。 | |||
T30969 |
Clitocine
|
Apoptosis; BCL | Apoptosis |
Clitocine 是一种来从蘑菇中提取的一种腺苷类似物,是一种有效的转录通读剂,是一种无义突变的抑制剂,具有抗癌活性,可诱导携带 p53 无义突变等位基因的细胞产生 p53 蛋白。Clitocine 通过促进 Mcl-1 降解来增强 TRAIL 介导的人结肠癌细胞凋亡。 | |||
T3824 |
Jaceosidin
|
Apoptosis; BCL; COX; UGT | Apoptosis; Immunology/Inflammation; Metabolism; Neuroscience |
Jaceosidin 是从毛莲蒿中得到的一种黄酮类天然产物,可激活Bax,下调 Mcl-1 和 c-FLIP 的表达,诱导癌细胞凋亡。它能够降低炎性因子水平,激活 NF-κB,抑制COX-2的表达,具有抗癌和抗炎作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02003 |
FH/Fumarate Hydratase Protein, Human, Recombinant (His)
fumarate hydratase,MCL,LRCC,MCUL1,FMRD,HLRCC |
Human | E. coli |
Fumarate Hydratase (FH) is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. Fumarate Hydratase is similar to some thermostable class II fumarases and func... | |||
TMPY-01643 |
CLEC4D Protein, Human, Recombinant (His)
CD368,MPCL,Dectin-3,CLEC-6,CLECSF8,C-type lectin domain fami... |
Human | HEK293 Cells |
CLEC4D Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.2 kDa and the accession number is Q8WXI8. | |||
TMPY-02293 |
CD23 Protein, Human, Recombinant (His)
MGC40078,CLEC6,MCL,BLAST-2,CD23A,IGEBF,FCE2,MPCL,CL... |
Human | HEK293 Cells |
CD23 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 33.2 kDa and the accession number is P06734-1. |